Head-to-head · Cost-Efficiency Index
Invigor Medical vs MaxLife
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Invigor Medical
Value shoppers who want competitive pricing on both molecules plus a wider wellness/hormone program on one account.
Visit Invigor MedicalMaxLife
Cost-first shoppers who want new patients specifically chasing the current limited-time promo, not for shoppers wanting stable published pricing.
Visit MaxLifeThe verdict
Invigor Medical takes it, leading the Cost-Efficiency Index 88 to 59. Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog. MaxLife still earns a C — Cost-first shoppers who want new patients specifically chasing the current limited-time promo, not for shoppers wanting stable published pricing.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Invigor Medical.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Invigor Medical | MaxLife |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 59/100 |
| Semaglutide / mo | $225/mo (starting dose) | $169/mo (compounded) |
| Tirzepatide / mo | $350/mo (starting dose) | $169/mo (compounded) |
| Semaglutide / yr (modeled) | $2,700 | $2,028 |
| Tirzepatide / yr (modeled) | $4,200 | $2,028 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #8 | #245 |
Invigor Medical
88/100Where the value is
- Competitive mid-market 'starting at' pricing on both semaglutide and tirzepatide
- Licensed in all 50 states, with a named Medical Director (Dr. Hamilton) and five named partner compounding pharmacies
- Both molecules published up front for easy cost modeling
The tradeoffs
- Both prices are floors — no dose-tier breakdown is published, so the real cost at a typical maintenance dose is unknown until intake
- The site names five partner pharmacies but never discloses which one fills a given order
MaxLife
59/100Where the value is
- Low advertised entry price ($169) plus a free first week for new clients
- Clear phone and email contact information for direct follow-up
- Simple, straightforward homepage messaging
The tradeoffs
- Headline price is explicitly a rotating seasonal promo ('March special'), not a stable rate
- No ongoing/renewal price disclosed anywhere after the promo period
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.